FDA Approves Once Weekly Insulin Icodec for Type 2 Diabetes
The US Food and Drug Administration has approved insulin icodec (Awiqli), developed by Novo Nordisk, as the first once-weekly long-acting basal insulin for glycemic control in adults with Type 2…